In vitro and in vivo stability and anti-tumour efficacy of an anti-EGFR/anti-CD3 F(ab')2 bispecific monoclonal antibody.

The in vitro and in vivo stability and anti-tumour efficacy of the anti-EGFR/anti-CD3 bispecific monoclonal antibody (biMAb), M26.1, were analysed. The interaction of the intact biMAb with Fc receptor I (Fc gamma RI) present on human leucocytes was not observed when the antibody was used as an F(ab&...

Descripción completa

Detalles Bibliográficos
Autores principales: Negri, D. R., Tosi, E., Valota, O., Ferrini, S., Cambiaggi, A., Sforzini, S., Silvani, A., Ruffini, P. A., Colnaghi, M. I., Canevari, S.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1995
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2034020/
https://www.ncbi.nlm.nih.gov/pubmed/7547242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2034020/
https://www.ncbi.nlm.nih.gov/pubmed/7547242

Ejemplares similares